Curtin University Homepage
  • Library
  • Help
    • Admin

    espace - Curtin’s institutional repository

    JavaScript is disabled for your browser. Some features of this site may not work without it.
    View Item 
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item
    • espace Home
    • espace
    • Curtin Research Publications
    • View Item

    Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome

    118369_Dose%20dependent%20effect%20of%20Rosuvastatin.pdf (951.5Kb)
    Access Status
    Open access
    Authors
    Ooi, E.
    Watts, G.
    Chan, D.
    Chen, Meifania
    Nestel, P.
    Sviridov, D.
    Barrett, H.
    Date
    2008
    Type
    Journal Article
    
    Metadata
    Show full item record
    Citation
    Ooi, Esther and Watts, Gerald and Chan, Dick and Chen, Meifania and Nestel, Paul and Sviridov, Dmitri and Barrett, Hugh. 2008. Dose-dependent effect of rosuvastatin on VLDL-apolipoprotein C-III kinetics in the metabolic syndrome. Diabetes Care. 31: pp. 1656-1661.
    Source Title
    Diabetes Care
    DOI
    10.2337/dc08-0358
    ISSN
    01495992
    Faculty
    Curtin Business School
    School of Information Systems
    School
    Centre for Extended Enterprises and Business Intelligence
    Remarks

    A link to the journal's website is available at: http://care.diabetesjournals.org/cgi/content/full/31/8/1656

    URI
    http://hdl.handle.net/20.500.11937/32130
    Collection
    • Curtin Research Publications
    Abstract

    OBJECTIVE-Dysregulated apolipoprotein (apo)C-III metabolism may account for hypertriglyceridemia and increased cardiovascular risk in the metabolic syndrome. This study investigated the dose-dependent effect of rosuvastatin on VLDL apoC-1II transport in men with the metabolic syndrome.RESEARCH DESIGN AND METHODS-Twelve men with the metabolic syndrome were studied in arandomized double-blind crossover trial of 5-week intervention periods with placebo, 10 mg rosuvastatin,or 40 mg rosuvastatin, with 2-week placebo washouts between each period. VLDL apoC-IlI kinetics were examined using a stable isotope method and compartmental modeling at the end ofeachintervention period.RESULTS-Compared with placebo, there was a significant dose-dependent reduction with rosuvastatinin plasma triglyceride and VLDL apoC-III concentrations. Rosuvastatin significantly (P < 0.05) increasedVLDL apoC-I1I fractional catabolic rate (FCR) and decreased its production rate, with a significant (P <0.05) dose-related effect. With 40 mg rosuvastatin, changes in VLDL apoC-I1I concentration wereinversely associated with changes in VLDL apoC-IIl FCR and positively associated with VLDL apoC-1IIproduction rate (P < 0.05). Changes in VLDL apoC-1II concentration and production rate were positivelycorrelated with changes in VLDL apoS concentration and production rate and inversely correlated with VLDL apoB FCR (P < 0.05). Similar associations were observed with 10 mg rosuvastatin but were either less or not statistically significant.CONCLUSIONS-In this study, rosuvastatin decreased the production and increased the catabolism of VLDL apoC-IIl, a mechanism that accounted for the significant reduction in VLDL apoC-llI and triglyceride concentrations. This has implications for the management of cardiometabolic risk in obese subjects with the metabolic syndrome.

    Related items

    Showing items related by title, author, creator and subject.

    • An investigation of the physiological and biochemical responses elicited by Panulirus cygnus to harvesting, holding and live transport.
      Spanoghe, Patrick T. (1996)
      The western rock lobster (WRL), Panulirus cygnus is a decapod crustacean which is found in abundance in the coastal waters of Western Australia and which supports a major fishery of economic importance for the State, with ...
    • Expression and modulation of tissue factor and tissue factor pathway inhibitor in an endothelial cell based model
      Ellery, Paul E. R. (2008)
      Haemostasis is a complex physiological process involving cellular and plasma protein components that interact to keep the blood fluid under normal conditions and prevent blood loss after vessel injury by promoting clot ...
    • Size exclusion chromatography as a tool for natural organic matter characterisation in drinking water treatment
      Allpike, Bradley (2008)
      Natural organic matter (NOM), ubiquitous in natural water sources, is generated by biogeochemical processes in both the water body and in the surrounding watershed, as well as from the contribution of organic compounds ...
    Advanced search

    Browse

    Communities & CollectionsIssue DateAuthorTitleSubjectDocument TypeThis CollectionIssue DateAuthorTitleSubjectDocument Type

    My Account

    Admin

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Follow Curtin

    • 
    • 
    • 
    • 
    • 

    CRICOS Provider Code: 00301JABN: 99 143 842 569TEQSA: PRV12158

    Copyright | Disclaimer | Privacy statement | Accessibility

    Curtin would like to pay respect to the Aboriginal and Torres Strait Islander members of our community by acknowledging the traditional owners of the land on which the Perth campus is located, the Whadjuk people of the Nyungar Nation; and on our Kalgoorlie campus, the Wongutha people of the North-Eastern Goldfields.